Table 2.

Factors associated with HAV vaccination of HAV nonimmune persons living with HIV who were men who have sex with men, persons who inject drugs, or both, 12-month retrospective observation period, United States, 2009–2012.

Characteristic	na	% vaccinated (N = 3640)b	95% CIb	P value for Rao-Scott chi-square test
Total	360	10	8.1–11.9
Age at time of interview (years)
18–29	101	25.9	21.4–30.3	<0.0001
30–39	87	15.2	10.7–19.7
40–49	103	8.4	6.0–10.8
≥50	69	4.6	3.2–6.0
Race/ethnicity
White, non-Hispanic	155	8.4	6.2–10.6	<0.0001
Black, non-Hispanic	127	14.3	11.3–17.2
Hispanic or Latino	59	8.1	5.4–10.7
Otherc	19	12	6.7–17.3
Sexual behavior/orientation
MSM	352	10	8.1–11.9	0.8
Non-MSMd	8	9.1	2.0–16.1
Injection drug use
Yes	19	12.1	6.2–18.0	0.43
No	341	9.9	8.1–11.8
Education
<High school	41	11.7	7.8–15.5	0.25
High school diploma or equivalent	89	11.2	8.3–14.1
>High school	230	9.4	7.4–11.4
Country or territory of birth
Born in foreign country	23	4.7	2.6–6.8	0.0008
Born in United States or Puerto Rico	337	10.6	8.5–12.8
Homeless at any time (during past 12 months)
Yes	27	12.2	7.4–17.1	0.26
No	333	9.8	7.9–11.7
Time since HIV diagnosis
<5 years	211	23.0	19.1–26.9	<0.0001
5–9 years	42	6.8	4.2–9.3
≥10 years	107	5.0	3.7–6.3
Prescribed ART
Yes	317	9.8	7.8–11.8	0.31
No	43	11.9	7.7–16.0
Sustained viral suppression in the past 12 months
Undetectable or <200 copies/mL	159	7.4	5.8–9.1	<0.0001
Detectable or ≥200 copies/mL	201	13.9	11.0–16.7
Received care at a Ryan White HIV/AIDS Program funded facility
Yes	251	14.3	12.3–16.4	<0.0001
No	64	4.1	2.5–5.6

Abbreviations: HAV, hepatitis A virus; HIV, human immunodeficiency virus; CI, confidence interval; MSM, men who have sex with men; ART, antiretroviral therapy; STD, sexually transmitted disease.

^aFrequencies are unweighted.

^bPercentages and corresponding CIs are weighted percentages.

^cIncludes American Indian/Alaska Native, Asian, Native Hawaiian/Other Pacific Islander, or multiple races.

^dCoefficient of variation >0.30 and this estimate may not be stable.